Systemically Administered Tempol Reduces Neuronal Activity in Paraventricular Nucleus of Hypothalamus and Rostral Ventrolateral Medulla in Rats
Journal of Hypertension - United States
doi 10.1097/hjh.0b013e3283200442
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2009
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)